FilingSEC EDGARS-8
Cadrenal Therapeutics Files Form S-8 for Equity Incentive Plan
· SEC accepted
StageRegistration
Filing content
Cadrenal Therapeutics has filed a Form S-8 to register an additional 323,542 shares of common stock issuable under its 2022 Equity Incentive Plan.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…